Answer to Question #316884 in Management for carol

Question

criticall analyse the misconduct of public officials that benefited in the PPE's and the covid-19 funds that were provided by government. In your discussion show how the criminal proceedings or penalties were taken to those public officials in government. 4 pages

Answer 1

The World Health Organization (WHO) declared the outbreak of a new coronavirus SARS-CoV-2 (COVID-19) a pandemic on 11 March 2020. Since then, the pandemic continues to rage, and morbidity and mortality rates continue to climb globally. This illuminates the urgency of developing and ensuring access to affordable, safe and efficacious vaccines, and their rapid and fair deployment. The positive results announced by a number of vaccine candidates in November 2020 have led to vaccines being approved at record speed in different parts of the world. A critical response will be required by governments to ensure access of their populations to safe and effective COVID-19 vaccines. Many governments have indicated that they aim to set up COVID-19 vaccine programmes that will cover their entire populations. The scale and complexity of the allocation, distribution and prioritization of the vaccines will therefore be unprecedented. WHO has activated the R&D Blueprint, a global strategy and preparedness plan to allow for the fast activation of research and development activities during epidemics. It aims to accelerate diagnostics, vaccines and therapeutics for COVID19 by improving coordination between scientists and global health professionals, accelerating the research and vaccination development process, and establishing new norms and standards to learn from and improve upon the global response.1 Furthermore, the WHO secretariat has reviewed and published a list of existing WHO guidance documents that are relevant to the development, production and evaluation of COVID-19 vaccines. The listing explains how current WHO standards may provide useful guidance and information for the development, production and evaluation of candidate COVID-19 vaccines.